Tag - novartis-pharma-k-k

 
Menu
Search
 
April 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

NOVARTIS PHARMA K K

Japan Times
JAPAN / Science & Health
May 15, 2019
Health insurance in Japan to cover new cancer therapy that costs ¥33 million
The anti-cancer drug Kymriah will be produced by a Tokyo-based unit of Novartis AG and is expected to carry the highest price tag of any single drug in Japan.
BUSINESS
Feb 3, 2015
Novartis Japan unit faces business suspension order
The health ministry will order a business suspension of around 15 days for a Japanese unit of Swiss pharmaceutical maker Novartis AG for not reporting serious side effects of its drugs, sources close to the matter said on Monday.
EDITORIALS
Sep 4, 2014
Novartis drug probe falls short
The Tokyo criminal probe into the manipulation of clinical data pertaining to the efficacy of a Novartis Pharma-marketed drug for blood pressure has failed to unravel the whole picture of the scandal.
Japan Times
JAPAN / EXPLAINER
Jan 13, 2014
Novartis drug's data-tampering reflects unchecked collusion
Last week, the Health, Labor and Welfare Ministry filed a criminal complaint with prosecutors against Novartis Pharma K.K., the Japanese subsidiary of Swiss pharmaceutical giant Novartis, alleging the firm made exaggerated advertising claims for its blockbuster blood pressure drug Diovan.
JAPAN / Crime & Legal
Jan 8, 2014
Ministry targets Novartis claims for legal action
The health ministry is making final arrangements to file a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug in violation of the pharmaceutical affairs law, ministry officials said Wednesday.
JAPAN / Crime & Legal
Dec 18, 2013
Novartis false ad complaint planned
The health ministry is planning to file a criminal complaint against Novartis Pharma K.K. over alleged use of false advertising for its Diovan blood pressure-lowering drug, officials said Wednesday.
Japan Times
JAPAN
Oct 31, 2013
Another study report on Novartis drug found inappropriate
Shiga University of Medical Science on Thursday became the third Japanese institution to conclude that a clinical study report on Novartis Pharma K.K.'s Diovan blood pressure-lowering drug contained doubtful data and was inappropriate.
EDITORIALS
Oct 19, 2013
Remedies for rigged research
It still isn't clear who manipulated clinical research data in favor of Novartis Pharma's blood-pressure drug Diovan, casting a cloud on the credibility of Japan's medical universities.
JAPAN
Jul 31, 2013
Another Japanese university finds data manipulation for Novartis drug
The Jikei University School of Medicine has become the second Japanese university to find that clinical data had been manipulated for a Novartis Pharma drug that lowers blood pressure.
JAPAN
Jul 30, 2013
No drug data manipulation: Novartis
Novartis Pharma K.K. said Monday it could find no evidence a former employee manipulated or altered clinical research data for the drugmaker's Diovan blood pressure-lowering drug.
JAPAN
Jul 29, 2013
Health ministry probes Diovan skin disruption reports
The health ministry is investigating reports of skin problems linked to the use of Diovan, Novartis Pharma K.K.'s popular drug for reducing high blood pressure, sources familiar with the matter said Monday.
Japan Times
JAPAN
Jul 12, 2013
Data in Novartis drug study manipulated
The data used in a clinical study on Novartis Pharma K.K.'s blockbuster blood pressure drug Diovan were manipulated, Kyoto Prefectural University of Medicine has revealed.
COMMENTARY / World
Sep 5, 2011
Japan in a European club?
Hitherto unknown and self-styled "loach" Yoshihiko Noda must learn to swim in an ocean of problems as Japan's new prime minister of the year. He has more than a plateful of domestic issues, but he should also realize, as his predecessors forgot, that Japan needs to re-engage the world if it is to find a way out of its depressing economic and political predicaments.
Akebono's human side eclipsed his incredible sumo achievements
The heights Akebono reached in sumo helped pave the way for future foreign-born yokozuna Asashoryu and Hakuho.
Death-row inmates' lawsuit targeting same-day notifications of executions dismissed
Two plaintiffs filed a lawsuit with Osaka District Court in hopes of sparking a wider discussion on the rights of death row prisoners.
Japan’s young workers head abroad as huge wage gap persists
The departure hall at Haneda Airport in Tokyo. Now with inflation at its strongest in decades, Japanese are starting to realize that years of static wages leave many of them budgeting each month before their next pay check.
By-elections to determine Kishida’s fate within LDP
LDP Secretary-General Toshimitsu Motegi and election strategy committee chair Yuko Obuchi speak to reporters in Tokyo on April 2.
For Modi, the Indian election is less about winning and more about by how much
Indian Prime Minister Narendra Modi addresses supporters during an election campaign rally in Pushkar, India, on April 6, ahead of the country's upcoming general election starting Friday.
For Modi, the Indian election is less about winning and more about by how much
Indian Prime Minister Narendra Modi addresses supporters during an election campaign rally in Pushkar, India, on April 6, ahead of the country's upcoming general election starting Friday.
Akebono's human side eclipsed his incredible sumo achievements
The heights Akebono reached in sumo helped pave the way for future foreign-born yokozuna Asashoryu and Hakuho.
Ohtani’s dizzying three weeks end in exoneration by authorities
Los Angeles Dodgers designated hitter Shohei Ohtani during a spring training game on March 12.
How ‘winged’ gyōza took flight from a Tokyo suburb
The creator of "hanetsuki gyōza" is Isao Yagi, and his restaurant, Nihao, can be found right on the border of Tokyo and Kawasaki in Ota Ward.
How Ippei Mizuhara allegedly wired millions from Shohei Ohtani’s account
Dodgers star Shohei Ohtani and his interpreter, Ippei Mizuhara, in December at SoFi Stadium in Inglewood, California

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on
By Lance Henderstein

SUSTAINABLE JAPAN

Prize winner Maki Imoto catches light with glass
Prize winner Maki Imoto catches light with glass

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER